FDMT Competitors & Alternatives
Compare 4D Molecular Therapeutics Inc with similar stocks in the same industry
Biotechnology
FDMT
Main Stock$9.15
Tradestie Score
55
Market Cap
$407.71M
Revenue Growth
216.6%
Analyst Upside
+208.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.61
|
$552.46M | - | 45 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.31
|
$540.97M | - | 45 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.76
|
$533.99M | - | 56 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.01
|
$529.35M | 5.8 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.23
|
$512.39M | - | 60 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$29.01
|
$505.12M | 1.7 | 60 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$108.64
|
$492.21M | - | 54 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.75
|
$474.20M | 26.8 | 53 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$5.13
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.15
|
$463.20M | - | 54 | Compare |
More FDMT Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry